Sponsors (8)
Introduced April 17, 2025 by David Joyce · Last progress April 17, 2025
The bill shifts federal policy to largely exempt state- and tribal-compliant marijuana activity—opening regulated interstate commerce, reducing criminal exposure, and improving safety standards—while imposing new federal taxes and regulations that raise compliance burdens, implementation challenges, potential fiscal trade-offs, and public-health/diversion risks.
People and businesses that comply with state or tribal marijuana laws will largely avoid federal criminal prosecution and CSA scheduling, reducing risk of federal charges for everyday licensed activity.
Compliant businesses gain important economic relief: protection from federal civil forfeiture, ability to claim tax deductions/credits (remedying IRC §280E limits), and clearer AML/banking treatment, improving profitability and access to financial services.
Federal consumer-safety and FDA regulation (manufacturing, contaminant testing, marketing limits, and postmarket reporting) will create clearer product-safety standards and specific youth protections, reducing risks from adulterated products and harmful marketing.
The bill creates substantial new regulatory complexity and cross-jurisdictional conflicts (state, tribal, federal) that will increase compliance costs, litigation risk, and operational uncertainty for businesses and regulators.
A new federal excise tax plus expanded compliance and testing requirements could raise retail prices and keep lawful market prices above illicit-market prices, limiting licensed market growth and raising costs for consumers.
Interstate transport exemptions and some expanded access (including medicinal transfers to under-21 patients in limited circumstances) could increase diversion and youth exposure if states and tribes do not coordinate strong safeguards.
Based on analysis of 9 sections of legislative text.
Removes most federal criminal penalties for marijuana compliant with State/Tribal law, creates TTB-run interstate regulation funded by an excise tax, and assigns FDA authority over marijuana products.
Creates a federal framework that removes most federal criminal penalties for marijuana that is manufactured, sold, possessed, or transported in compliance with State or federally recognized Indian Tribe law, establishes federal regulation of interstate cannabis commerce (administered by the Alcohol and Tobacco Tax and Trade Bureau) funded by a federal excise tax on cannabis, and assigns FDA authority to regulate marijuana products consistent with existing drug/food/cosmetic categories or by a newly required rule for items that don’t fit those categories. It also narrows certain enhanced federal criminal penalties, directs the Attorney General and HHS/FDA to issue regulations within 180 days, requires a GAO study on traffic safety within one year, and exempts compliant transactions from certain federal forfeiture, tax (IRC §280E), and money-laundering consequences.